SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-178596
Filing Date
2021-06-01
Accepted
2021-06-01 16:29:29
Documents
4
Period of Report
2021-07-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A d105885ddef14a.htm DEF 14A 290509
2 GRAPHIC g105885g81k15.jpg GRAPHIC 55398
3 GRAPHIC g105885page001.jpg GRAPHIC 131413
4 GRAPHIC g105885page002.jpg GRAPHIC 128407
  Complete submission text file 0001193125-21-178596.txt   721622
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39634 | Film No.: 21985691
SIC: 2834 Pharmaceutical Preparations